Abstract-Keyhole lympet hemocyanin (KLH)-specific suppressor T (Ts) cells that suppress the in vitro secondary anti-trinitrophenyl (TNP) PFC response to TNP-KLH could be induced when murine spleen cells were precultured with KLH.
N-(2-carboxyphenyl)-4-chloroanthranilic acid disodium salt (CCA) is a compound that has been shown to be clinically effective as an anti-rheumatic drug (1). Although the precise mechanism of action of this drug still remains unknown, it appears to exert its therapeutic effects by modulating immunological pro cesses (2-8). We have reported that CCA showed suppressive effects on the enhanced antibody response to sheep erythrocytes (SRBC), but was augmentative on the lowered response (5, 6). Namely, CCA showed immunopotentiating effects when antibody responses were lowered under the following conditions: a) Decreasing the amount of antigen to a suboptimal level (4 6), b) Administration of an immuno suppressive agent like hydrocortisone (7). The drug, on the contrary, had immuno suppressive effects when it was applied to the enhanced immune responses as follows: a) The spontaneously enhanced antibody response in NZB/NZW F, mice (3, 5, 6), b) The secondary antibody response to SRBC, c) The enhanced response to trinitrophenyl (TNP)-human gammaglobulin (HGG) induced by colchicine injection (5, 6). On the other hand, Ohsugi et al. have reported that CCA enhanced blastformation of thymocytes induced by concanavalin A (Con A) in NZB/NZW F, mice (3). We have also reported that CCA had almost no effects on the antibody response to a thymus independent antigen, DNP-Ficoll, or the proliferative response to lipopolysaccharide (LPS), a B cell mitogen in normal mice (5, 6). These results suggest that CCA might be a compound possessing a profile as an immunomodulator that would modify T cell functions. In the present paper, we examined the effect of CCA on the induction of sup pressor T (Ts) cells or helper T (Th) cells both in vivo and in vitro.
Materials and Methods

Materials
Female BALB/c mice were purchased from Japan Charles River (Tokyo, Japan) and used during 8-12 weeks of age. CCA was supplied from Chugai Pharmaceutical Co. Ltd. (Tokyo, Japan). Other materials were obtained from the following sources: fetal calf serum (FCS) (GIBCO, Gland Island, NY and Nishi-Nippon Sheep Farm, Fukuyama, Japan), 2-mercaptoethanol (2 ME) (Tokyo Chemical Industry, Tokyo, Japan), RPMI-1 640 medium (Nissui Seiyaku, Tokyo, Japan), SRBC (Nishinippon Sheep Farm, Fukuyama, Japan), Con A (E.Y. Laboratories, San Mateo, CA), HGG (Sigma Chemical Company, St. Louis, MO), Keyhole lympet hemocyanin (KLH) (Calbiochem Behring Corp., La Jolla, CA). TNP-HGG or TNP-KLH was prepared as described by Haba and Hamaoka (9) or Rittenberg and Amkraut (10), respectively. Antigen doses were expressed as icg protein/ml or ,ug protein/ body for in vitro or in vivo experiments, respectively. Antibody response in vitro By using a NUNC multi-dish culture plate with 24 wells (NUNC, Kamstrup, Denmark), BALB/c spleen cells (0.6-1.0x106) were cultured with 2x106 SRBC or 0.1-1.0 /cg/ml TNP-KLH in 2 ml of RPMI-1640 medium supplemented with 10% FCS, 1 X10-5 M 2-ME, 50 ug/ml streptomycin and 50 ag/ml penicillin G at 37°C for 4-5 days under 5% C02 and 95% air. Plaque-forming cells (PFC) were enumerated according to the method of Jerne and Nordin (11 ). The number of indirect PFC was calculated by subtracting the number of the direct PFC from the number of plaques detected in the presence of rabbit anti-mouse IgG serum (1:10,000). Lightly conjugated TNP-SRBC were prepared by the modified method of Rittenberg and Pratt (12) and used for assaying anti-TNP PFC. Induction of antigen-specific Ts cell
In vitro: For the induction of KLH-specific Ts cells, spleen cells (6x106) from BALB/c mice were cultured with 10-100 cg/ml KLH for 4 days. The cells were collected, washed and counted for the number of viable cells. The viable cells (2-8x105) were added to the freshly prepared spleen cells (6x106) from TNP-KLH-primed mice and were cultured with TNP-KLH (0.1 ,ug/ml) for 5 days. The control culture received the same number of viable cells which were precultured in the absence of KLH for 4 days. The activity of Ts cells was estimated as the degree of suppression of secondary anti-TNP immune response to TNP-KLH. Mice were primed with TNP-KLH by the intraperitoneal injection of TNP-KLH (100 ag) absorbed on 4 mg of aluminum hydroxide gel (alum) 1-2 months prior to use.
In vivo: Mice were injected intraperitoneally with 100 icg KLH dissolved in saline twice at 2 weeks of interval as reported by Tada and Takemori (13) . Two weeks after the second injection, these mice were sacrificed, and their spleens were removed. The viable spleen cells (5 X 103-5 X 105) were added to the freshly prepared spleen cells (6x106) from TNP-KLH-primed mice as described above. Then, the Ts cells activity was determined in the same way as above. In vivo induction of Ts cells by Con A Ts cells were induced by the injection of 150 i.ig/body Con A intravenously 24 hr before immunization with SRBC (2X108) according to the procedure of Rich and Pierce (14) . Ts cell activity was estimated as the suppression of anti-SRBC PFC response. Induction of antigen-specific Th cells In vitro: For the induction of HGG-specific Th cells, spleen cells (1 X 107) were cultured with 0.01-0.1 eg/ml HGG for 4 days as described by Kontiainen and Feldmann (15) . The cells were collected, washed and counted for the number of viable cells. The educated viable cells (2x105) were added to the freshly prepared spleen cells (1 X 107) and cultured with TNP-HGG (0.1 iig/ml) for 4 days. The control culture received the same number of viable cells that were pre cultured in the absence of HGG. In this experiment, all cultures were performed according to Marbrook's method (15) .
In vivo: KLH-specific Th cells were induced in vivo by the 1ntraperitonea I injection of KLH (30-100 gig) absorbed on 4 mg of alum. Four weeks after KLH injection, these mice were sacrificed, and their spleens were removed. The viable spleen cells (1 X 107) were cultured with TNP-KLH (1 /cg/ml) for 4 days. Then, Th cell activity was estimated by enumerating the number of anti-TNP direct PFC.
Results
Induction of KLH-specific Ts cells in vitro:
Spleen cells that were precultured with 10 100 ttg/ml KLH for 4 days suppressed the secondary anti-TNP PFC response to TN P KLH in TNP-KLH-primed spleen cells in a dose-dependent manner (Fig. 1A) . According to our preliminary experiments, 100 ug/ml KLH was found to induce Ts cell activity maximally. It has been pointed out that the culture of lymphocytes in the absence of added antigen often resulted in the generation of non-specific suppressor activity (16) . We also confirmed that this was the case. Some components in FCS appears to be involved in this phenomenon (16) . Thus, it is difficult to observe antigen-specific Ts cell activity under these experimental conditions. We tested a variety of lots of FCS and found a lot (NSF 107) that did not induce such a non specific suppressor activity. By using this lot of FCS, we succeeded in the in vitro induction and assay of antigen-specific Ts cells.
The induced suppressor activity was specifically abrogated by the treatment with anti-Thy-1,2 plus complement (13), thus indicating that antigen-induced Ts cells were involved in the suppression as shown in Fig. 1 B. Ts cell activity appeared to be specific for the carrier protein of the antigen because no inhibition was observed with anti-SRBC response. These properties resemble those of KLH-specific Ts cells reported by Kontiainen and Feldmann (17) .
Effect of CCA on the induction of KLH specific Ts cells in vitro and in vivo: Under our experimental conditions, the maximal Ts cell induction was attained with 100 beg/ml KLH in vitro. CCA at 1-100 /cg/ml aug mented the induction of Ts cells when a suboptimal dose of KLH (10 ;ug/ml) was used for the induction. However, the drug showed opposite effects when Ts cells were induced with an optimal dose of KLH (100 lug/ml) as shown in Fig. 2A .
On the other hand, it has been reported that antigen-specific Ts cells can be induced in vivo by injecting KLH without adjuvant twice at 2 weeks of interval (13) . We also confirmed that optimal Ts cell activity was generated with 100 itg/body KLH. Ts cells thus induced were assayed for their activity in vitro using TNP-KLH-primed cells as described in Fig. 2A . Almost similar results to those of in vitro experiments were obtained when mice received 10 mg/kg CCA daily for 4 weeks after the first injection of KLH. Namely, CCA inhibited the induction of Ts cells when an optimal dose of KLH was used for the induction. As shown in Fig. 2B , Ts cell induction, however, was not inhibited but rather slightly augmented when Ts cells were induced with 30 dig/body KLH that was found to be a suboptimal dose.
Effect of CCA on the induction of Ts cells by Con A in vivo: Primary anti-SRBC PFC response in mice were reported to be sup pressed by the injection of Con A 24 hr prior to immunization (14) . This suppression was found to be mediated by Con A-induced non-specific Ts cells (14) . In our experiments, Con A injection resulted in the suppression of the antibody response to approx. 3% of the control level. Daily administration of 10-50 mg/kg CCA for 7 days starting 2 days before Con A injection did not reverse the suppressed response as shown in Table 1 (1 x 107) were precultured with HGG for 4 days in the presence or absence of 1 ,ug/ml CCA. Then, these cells (2x 105) were cultured in triplicate with fresh unprimed spleen cells (1 x 107) for 4 days in the presence of 0.1 ug/ml TNP-HGG. All cultures in this experiment were performed by Marbrook's method. antigen. As illustrated in Fig. 3 , addition of carrier-primed lymphocytes resulted in the augmentation of anti-TNP response to TNP HGG, suggesting that HGG induced Th cell activity. Thus, CCA was examined for its effect on Th cell induction. As depicted in Fig. 3, CCA (1 i g/ml) augmented the induction of Th cells when Th cells were induced by a suboptimal dose of HGG (0.01 ,ug/ml) (15) . On the other hand, CCA did not affect Th cell activity when an optimal dose of HGG (0.1 /cg/ml) (15) was employed for the induction.
Effect of CCA on the induction of Th cell activity in vivo: Th cells can also be induced in vivo. Unprimed spleen cells could not elicit primary anti-TNP PFC response to TNP-KLH in vitro. However, a significant number of anti-TNP PFC were observed when KLH-primed spleen cells were cultured with TNP-KLH, thus indicating that Th cell activity was induced by the immunization with KLH (Data not shown). Administration of 10 mg/ kg CCA every other day for 4 weeks after priming with KLH augmented the induction of Th cells when a low dose of KLH (30 /-,g/ body) was employed for the induction (Fig.  4) . Moreover, much higher enhancement was obtained by CCA administration daily for only the initial 4 days after KLH-priming. The augmentative effect, however, was not observed when Th cells were induced by a high dose of KLH (100 /lg/body) as shown in Fig. 4 .
Discussion
Our data and those of other authors obtained from in vitro and in vivo experiments demonstrated that CCA exerts its immuno modulating activities by acting on Ts and Th cells. In summary, CCA could a) restore the activity of Ts cells suppressed by colchicine pretreatment (5, 6), b) suppress spontaneously enhanced antibody response in NZB/NZW F, mice (5, 6), c) enhance blastformation of thymocytes induced by Con A in NZB/NZW F, mice in which Ts cell activity is known to decline with age (3), d) augment the induction of antigen-specific Ts cells when suboptimal doses of antigen were used for the induction (Fig. 2) , and e) suppress Ts cell induction by an optimal amount of antigen (Fig. 2) . Furthermore, it was shown in this paper that the drug also augmented the induction of antigen-specific Th cells when the cells were induced by suboptimal doses of antigen (Figs. 3, 4) . These data demonstrated that CCA would exert either enhancing or suppressive effects depending on the magnitude of the immune responses.
Therefore, CCA would fall into the category of an immunomodulator.
Previous reports from our laboratory on the immunomodulating properties of CCA showed that CCA suppresses the antibody response to T cell-dependent antigens when an optimal amount of antigen was present in the culture, while the drug did not suppress but rather enhanced the response when spleen cells were cultured with a suboptimal dose of the antigen (5, 6). Such a modulating activity was not observed with the response to T cell-independent antigen, suggesting that CCA modulates the functions of im munocompetent cells at the T cell level. Tamura and Ishizaka have reported that antibody response is highly dependent on the dose of immunogen in IgE antibody responses (18) , i.e., antigen-specific Th cells were induced by the immunization with a lower dose of antigen, and Ts cells by a higher dose of antigen. Antibody response in vitro was found to be dependent on the cell density in the culture; a higher response was obtained at a higher cell-density and a lower response at a lower density. It has been reported that an antibody response is limited by Ts cells in the culture of higher cell density, but by Th cells in the lower cell density culture (19 6) . In the present paper, we showed that CCA is able to enhance or suppress the activities of both Ts and Th cells depending on the dose of antigens. It is likely that the drug would stimulate a T cell population that is more weakly activated, thus resulting in the modulation of the immune response to a normal level. On the other hand, it seems interesting to consider these T cell-activating effects of CCA in relation to its enhancing effect on the intrathymic level of both cyclic GMP and thymosin (8).
